{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:47:17Z","timestamp":1773384437464,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.radonc.2022.06.017","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T19:06:52Z","timestamp":1656184012000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A decision support framework for postoperative radiotherapy in patients with pathological N2 non-small cell lung cancer"],"prefix":"10.1016","volume":"173","author":[{"given":"Chen-Chen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Long","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.radonc.2022.06.017_b0005","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jtcvs.2015.12.028","article-title":"Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis","volume":"151","author":"Yang","year":"2016","journal-title":"J Thoracic Cardiovas Surg"},{"issue":"3","key":"10.1016\/j.radonc.2022.06.017_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.seminoncol.2017.10.009","article-title":"Management of stage III non-small cell lung cancer","volume":"44","author":"Tabchi","year":"2017","journal-title":"Semin Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2022.06.017_b0015","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaoncol.2021.1910","article-title":"Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: the phase 3 PORT-C randomized clinical trial","volume":"7","author":"Hui","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2022.06.017_b0020","first-page":"921","article-title":"Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer","volume":"9","author":"Lei","year":"2016","journal-title":"OncoTargets Therapy"},{"issue":"8","key":"10.1016\/j.radonc.2022.06.017_b0025","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2014.58.5380","article-title":"Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2022.06.017_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/JTO.0000000000000406","article-title":"Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database","volume":"10","author":"Corso","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2022.06.017_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.radonc.2013.10.008","article-title":"Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial","volume":"110","author":"Shen","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2022.06.017_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lungcan.2014.02.016","article-title":"Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancer","volume":"84","author":"Patel","year":"2014","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"5","key":"10.1016\/j.radonc.2022.06.017_b0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cllc.2014.05.005","article-title":"Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis","volume":"15","author":"Kim","year":"2014","journal-title":"Clinical Lung Cancer"},{"issue":"2","key":"10.1016\/j.radonc.2022.06.017_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijrobp.2009.05.044","article-title":"A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease","volume":"77","author":"Zou","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.radonc.2022.06.017_b0055","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1200\/JCO.2005.04.6110","article-title":"Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database","volume":"24","author":"Lally","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2022.06.017_b0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial","volume":"23","author":"Le Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.radonc.2022.06.017_b0065","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jtho.2018.08.2021","article-title":"Survival patterns for patients with resected N2 non-small cell lung cancer and postoperative radiotherapy: A Prognostic scoring model and heat map approach","volume":"13","author":"Deng","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.radonc.2022.06.017_b0070","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/JTO.0b013e318292c53e","article-title":"Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer","volume":"8","author":"Urban","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2022.06.017_b0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2021.04.009","article-title":"Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study","volume":"156","author":"Zhang","year":"2021","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"11","key":"10.1016\/j.radonc.2022.06.017_b0080","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/JTO.0000000000000334","article-title":"The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer","volume":"9","author":"Rami-Porta","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2022.06.017_b0085","series-title":"General Rules for Clinical and Pathological Records of Lung Cancer","author":"The Japan Lung Cancer Society","year":"2010"},{"issue":"1","key":"10.1016\/j.radonc.2022.06.017_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","article-title":"Complete resection in lung cancer surgery: proposed definition","volume":"49","author":"Rami-Porta","year":"2005","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"2","key":"10.1016\/j.radonc.2022.06.017_b0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.radonc.2022.06.017_b0100","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jtho.2016.06.014","article-title":"The clinical impact of solid and micropapillary patterns in resected lung adenocarcinoma","volume":"11","author":"Yanagawa","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"13","key":"10.1016\/j.radonc.2022.06.017_b0105","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2022.06.017_b0110","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtcvs.2017.11.098","article-title":"A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery","volume":"155","author":"Mao","year":"2018","journal-title":"J Thorac Cardiovasc Surgery"},{"key":"10.1016\/j.radonc.2022.06.017_b0115","first-page":"19","article-title":"Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes","volume":"41","author":"Matsuguma","year":"2012","journal-title":"Eur J Cardio-thorac Surg"},{"key":"10.1016\/j.radonc.2022.06.017_b0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2019.05.020","article-title":"Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio","volume":"133","author":"Shinde","year":"2019","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"26","key":"10.1016\/j.radonc.2022.06.017_b0125","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2015.60.9818","article-title":"Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival","volume":"33","author":"Ujiie","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2022.06.017_b0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000478-200203000-00010","article-title":"Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance","volume":"26","author":"Amin","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.radonc.2022.06.017_b0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/JTO.0b013e318241780e","article-title":"Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes","volume":"7","author":"Maeda","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2022.06.017_b0140","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cncr.33985","article-title":"Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer","volume":"128","author":"Li","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.06.017_b0145","article-title":"Perioperative ctDNA-based molecular residual disease detection for non-small cell lung cancer: A prospective multicenter cohort study (LUNGCA-1)","author":"Xia","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.radonc.2022.06.017_b0150","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2022.06.017_b0155","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jtcvs.2017.10.075","article-title":"Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer","volume":"155","author":"Zheng","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.radonc.2022.06.017_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ejcts\/ezaa042","article-title":"Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer","volume":"58","author":"Yun","year":"2020","journal-title":"Eur J Cardio-thorac Surg"},{"issue":"2","key":"10.1016\/j.radonc.2022.06.017_b0165","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jtho.2016.09.135","article-title":"Role of postoperative radiotherapy in pathologic stage IIIA (N2) non-small cell lung cancer in a prospective nationwide oncology outcomes database","volume":"12","author":"Herskovic","year":"2017","journal-title":"J Thorac Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:25:13Z","timestamp":1759123513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022041780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":33,"alternative-id":["S0167814022041780"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.06.017","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decision support framework for postoperative radiotherapy in patients with pathological N2 non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}